SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · Four corporate insiders at United Therapeutics, including the CEO, CFO,…

UNITED THERAPEUTICS Corp · CLUSTER filed Apr 16, 2026 at 16:31 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Apr 16, 2026 at 16:31 ET

Four corporate insiders at United Therapeutics, including the CEO, CFO, and General Counsel, conducted open-market share sales totaling $1.29 million over a 7-day window, following derivative exercises. The net direction is clearly selling, with the largest individual sale by a director accounting for nearly half the total value.

  • CEO Martine Rothblatt sold $89,732 in open-market transactions and exercised derivatives worth over $3.8 million in non-cash transactions.
  • CFO James Edgemond sold $503,649 in shares after exercising options valued at $2.7 million.
  • Director Christopher Patusky sold $578,880 of shares, the largest single transaction in the cluster.
  • General Counsel Paul Mahon sold $114,807 in shares following derivative exercises worth $1.2 million.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access